Association of Fluoroquinolone Prescribing Rates With Black Box Warnings from the US Food and Drug Administration

IMPORTANCE: In 2013 and 2016, the US Food and Drug Administration (FDA) issued warnings and recommended limited use of fluoroquinolones for patients with certain acute conditions. It is not clear how prescribers have responded to these warnings. OBJECTIVE: To analyze changes in prescribing of fluoro...

Descripción completa

Detalles Bibliográficos
Autores principales: Sankar, Ashwini, Swanson, Kristi M., Zhou, Jiani, Jena, Anupam Bapu, Ross, Joseph S., Shah, Nilay D., Karaca-Mandic, Pinar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Medical Association 2021
Materias:
Original Investigation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8637256/
https://www.ncbi.nlm.nih.gov/pubmed/34851398
http://dx.doi.org/10.1001/jamanetworkopen.2021.36662

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8637256/
https://www.ncbi.nlm.nih.gov/pubmed/34851398
http://dx.doi.org/10.1001/jamanetworkopen.2021.36662

Ejemplares similares